ישראל -
עברית -
Ministry of Health
msas: vantage; professional; b.e.s.t.; partner;;
ביוקונטרול - מומחה - glvanic skin response measurement device
ישראל -
עברית -
Ministry of Health
msas: vantage; professional; b.e.s.t.; partner;;
ביוקונטרול - מומחה - glvanic skin response measurement device
ישראל -
עברית -
Ministry of Health
tes (tattoo erazer system)
hawk medical technologies ltd. - מומחה - the tes device is intended for the removal of tattoos in various colors and body locations following toxic or immunologic response of the skin.
ישראל -
עברית -
Ministry of Health
ריספונד תמיסה
unipharm ltd, israel - risperidone - תמיסה - risperidone 1 mg/ml - risperidone - risperidone - rispond is indicated for the management of schizophrania and manifestation of psychotic disorders. the antipsychotic efficacy of rispond was established in short-term (6 to 8 weeks) controlled trials of schizophrenic inpatients. rispond is also effective in maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response. rispond is indicated for the treatment of psychotic manifestations of dementia. conduct and other disruptive disorders: treatment of behavioral disorders expressed by impulse control disorders or self-alienated-aggressive or treatment- requiring behavioral disorders with reduced or substandard intelligence. treatment should not be given to children under the age of 5 years. rispond is indicated for the treatment of mania in bipolar disorder. these episodes are characterized by symptoms such as elevated expansive or irritable mood inflated self-esteem decreased need for sleep pressured speech racing thoughts distractibility or poor judg
ישראל -
עברית -
Ministry of Health
osseopulse-bone regeneration system
"ס. י. ר. א. מ. בע""מ" - רופא - סיוע וזירוז בהיווצרות והחלמת עצם לאחר השתלות דנטליות
ישראל -
עברית -
Ministry of Health
fiber optic surgical lights, camera, video systems & accessories
גאמידה בע"מ - רופא - מערכות תאורה, צילום ותיעוד רפואי בחדרי ניתוח ובמרפאות
ישראל -
עברית -
Ministry of Health
devices and reagents for cardiac markers, infectious disease and rapid test
מדיגל בע"מ - מומחה
ישראל -
עברית -
Ministry of Health
טמבוקור 100 מג טבליות
megapharm ltd - flecainide acetate - טבליה - flecainide acetate 100 mg - flecainide - flecainide - serious sustained life threatening ventricular arrhytmias that have not responsed to other drugs. paroxymal atrial flutter.
ישראל -
עברית -
Ministry of Health
פרבנאר 13
pfizer pharmaceuticals israel ltd - pneumococcal polysaccharide serotype 1; pneumococcal polysaccharide serotype 14; pneumococcal polysaccharide serotype 18c; pneumococcal polysaccharide serotype 19 f; pneumococcal polysaccharide serotype 19a; pneumococcal polysaccharide serotype 23f; pneumococcal polysaccharide serotype 3; pneumococcal polysaccharide serotype 4; pneumococcal polysaccharide serotype 5; pneumococcal polysaccharide serotype 6a; pneumococcal polysaccharide serotype 6b; pneumococcal polysaccharide serotype 7f; pneumococcal polysaccharide serotype 9v - תרחיף להזרקה - pneumococcal polysaccharide serotype 23f 2.2 mcg / 0.5 ml; pneumococcal polysaccharide serotype 19 f 2.2 mcg / 0.5 ml; pneumococcal polysaccharide serotype 14 2.2 mcg / 0.5 ml; pneumococcal polysaccharide serotype 9v 2.2 mcg / 0.5 ml; pneumococcal polysaccharide serotype 7f 2.2 mcg / 0.5 ml; pneumococcal polysaccharide serotype 6b 4.4 mcg / 0.5 ml; pneumococcal polysaccharide serotype 5 2.2 mcg / 0.5 ml; pneumococcal polysaccharide serotype 4 2.2 mcg / 0.5 ml; pneumococcal polysaccharide serotype 1 2.2 mcg / 0.5 ml; pneumococcal polysaccharide serotype 3 2.2 mcg / 0.5 ml; pneumococcal polysaccharide serotype 6a 2.2 mcg / 0.5 ml; pneumococcal polysaccharide serotype 18c 2.2 mcg / 0.5 ml; pneumococcal polysaccharide serotype 19a 2.2 mcg / 0.5 ml - pneumococcus, purified polysaccharides antigen conjugated - pneumococcus, purified polysaccharides antigen conjugated - active immunisation for the prevention of disease caused by streptococcus pneumoniae serotypes 1,3,4,5,6a, 6b, 7f, 9v, 14,18c,19a,19f, 23f (including sepsis, meningitis, bacteraemia, pneumonia and acute otitis media) in infants and children from 2 months to 5 years of age.in adults 50 years of age and older, prevnar 13 is indicated for: active immunization for the prevention of pneumonia and invasive disease caused by streptococcus pneumoniae serotypes 1, 3, 4, 5, 6a, 6b, 7f, 9v, 14, 18c, 19a, 19f and 23f. this indication is based on immune responses elicited by prevnar 13. there have been no controlled trials in adults demonstrating a decrease in invasive pneumococcal disease or pneumococcal pneumonia after vaccination with prevnar 13.